Literature DB >> 28124770

The Effect of Stereotactic Injections on Demyelination and Remyelination: a Study in the Cuprizone Model.

Laura Salinas Tejedor1,2, Tanja Wostradowski1,2, Stefan Gingele1, Thomas Skripuletz1, Viktoria Gudi3, Martin Stangel1,2.   

Abstract

Remyelination is the natural repair mechanism in demyelinating disorders of the central nervous system (CNS) such as multiple sclerosis. Several animal models have been used to study demyelination and remyelination. Among toxic animal models, oral administration of the toxin cuprizone leads to white and gray matter demyelination. In contrast, focal demyelination models include the stereotactic application of a toxin such as lysolecithin or ethidium bromide. The injection procedure generates a local disruption of the blood-brain barrier (BBB) and might thus trigger a local inflammatory reaction and consequently may influence demyelination and remyelination. In order to study such consequences, we applied stereotactic injections in the cuprizone model where demyelination and remyelination are mediated independent of this procedure. Immunohistochemistry was performed to detect the presence of lymphocytes and activated glial cells in the injection area. Blood protein stainings were used to assess the integrity of the BBB and myelin staining to evaluate demyelination and remyelination processes. Stereotactic injection led to a local disruption of the BBB as shown by local extravasation of blood proteins. Along the injection canal, T and B lymphocytes could be detected and there was a tendency of a higher microgliosis and astrocytosis. However, these changes did not influence demyelination and remyelination processes at the site of injection, in the corpus callosum, or in the cerebral cortex. Our results suggest that a local stereotactic injection has no major impact on CNS demyelination and remyelination.

Entities:  

Keywords:  Corpus callosum; IgG; Immunohistochemistry; Intraventricular; cannula’s track

Mesh:

Substances:

Year:  2017        PMID: 28124770     DOI: 10.1007/s12031-017-0888-y

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  34 in total

1.  ELISA methodology to quantify astrocyte production of cytokines/chemokines in vitro.

Authors:  Hongwei Qin; Etty N Benveniste
Journal:  Methods Mol Biol       Date:  2012

2.  Identification of a microglia phenotype supportive of remyelination.

Authors:  Marta Olah; Sandra Amor; Nieske Brouwer; Jonathan Vinet; Bart Eggen; Knut Biber; Hendrikus W G M Boddeke
Journal:  Glia       Date:  2011-11-09       Impact factor: 7.452

3.  Characterisation of microglia during de- and remyelination: can they create a repair promoting environment?

Authors:  Elke Verena Voss; Jelena Škuljec; Viktoria Gudi; Thomas Skripuletz; Refik Pul; Corinna Trebst; Martin Stangel
Journal:  Neurobiol Dis       Date:  2011-09-21       Impact factor: 5.996

4.  The synthesis of serum proteins on attached rather than free ribosomes of rat liver.

Authors:  C M Redman
Journal:  Biochem Biophys Res Commun       Date:  1968-06-28       Impact factor: 3.575

5.  Tumor necrosis factor alpha expression produces increased blood-brain barrier permeability following temporary focal cerebral ischemia in mice.

Authors:  G Y Yang; C Gong; Z Qin; X H Liu; A Lorris Betz
Journal:  Brain Res Mol Brain Res       Date:  1999-05-21

6.  Oligodendroglial markers in the cuprizone model of CNS de- and remyelination.

Authors:  Laura Salinas Tejedor; Viktoria Gudi; Valeria Kucman; Refik Pul; Stefan Gingele; Kurt-Wolfram Sühs; Martin Stangel; Thomas Skripuletz
Journal:  Histol Histopathol       Date:  2015-06-25       Impact factor: 2.303

7.  Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy.

Authors:  E A van Vliet; S da Costa Araújo; S Redeker; R van Schaik; E Aronica; J A Gorter
Journal:  Brain       Date:  2006-11-22       Impact factor: 13.501

8.  Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent.

Authors:  Thomas Skripuletz; Maren Lindner; Alexandra Kotsiari; Niklas Garde; Jantje Fokuhl; Franziska Linsmeier; Corinna Trebst; Martin Stangel
Journal:  Am J Pathol       Date:  2008-03-18       Impact factor: 4.307

9.  Multiple sclerosis.

Authors:  Alastair Compston; Alasdair Coles
Journal:  Lancet       Date:  2008-10-25       Impact factor: 79.321

Review 10.  Cuprizone-induced demyelination as a tool to study remyelination and axonal protection.

Authors:  Adib Zendedel; Cordian Beyer; Markus Kipp
Journal:  J Mol Neurosci       Date:  2013-05-12       Impact factor: 3.444

View more
  9 in total

1.  Cuprizone-Containing Pellets Are Less Potent to Induce Consistent Demyelination in the Corpus Callosum of C57BL/6 Mice.

Authors:  Tanja Hochstrasser; Gianna Lisa Exner; Stella Nyamoya; Christoph Schmitz; Markus Kipp
Journal:  J Mol Neurosci       Date:  2017-02-25       Impact factor: 3.444

2.  Unconventional Myosin ID is Involved in Remyelination After Cuprizone-Induced Demyelination.

Authors:  Reiji Yamazaki; Hiroko Baba; Yoshihide Yamaguchi
Journal:  Neurochem Res       Date:  2017-10-06       Impact factor: 3.996

3.  CD8 T-cell Recruitment Into the Central Nervous System of Cuprizone-Fed Mice: Relevance to Modeling the Etiology of Multiple Sclerosis.

Authors:  Mohammed S M Almuslehi; Monokesh K Sen; Peter J Shortland; David A Mahns; Jens R Coorssen
Journal:  Front Cell Neurosci       Date:  2020-03-10       Impact factor: 5.505

4.  Suppression of the Peripheral Immune System Limits the Central Immune Response Following Cuprizone-Feeding: Relevance to Modelling Multiple Sclerosis.

Authors:  Monokesh K Sen; Mohammed S M Almuslehi; Erika Gyengesi; Simon J Myers; Peter J Shortland; David A Mahns; Jens R Coorssen
Journal:  Cells       Date:  2019-10-24       Impact factor: 6.600

5.  Protein Nanoparticle-Related Osmotic Pressure Modifies Nonselective Permeability of the Blood-Brain Barrier by Increasing Membrane Fluidity.

Authors:  Chen Li; LinLin Chen; YuanYuan Wang; TingTing Wang; Dong Di; Hao Zhang; HuanHuan Zhao; Xu Shen; Jun Guo
Journal:  Int J Nanomedicine       Date:  2021-03-01

6.  Blockade of Indoleamine 2, 3-dioxygenase 1 ameliorates hippocampal neurogenesis and BOLD-fMRI signals in chronic stress precipitated depression.

Authors:  Lei Gao; Tingting Gao; Ting Zeng; Peng Huang; Nai-Kei Wong; Zhaoyang Dong; Yunjia Li; Guanghui Deng; Zhiyong Wu; Zhiping Lv
Journal:  Aging (Albany NY)       Date:  2021-02-11       Impact factor: 5.682

7.  Revisiting the Pathoetiology of Multiple Sclerosis: Has the Tail Been Wagging the Mouse?

Authors:  Monokesh K Sen; Mohammed S M Almuslehi; Peter J Shortland; Jens R Coorssen; David A Mahns
Journal:  Front Immunol       Date:  2020-09-29       Impact factor: 7.561

Review 8.  Engineered exosomes: desirable target-tracking characteristics for cerebrovascular and neurodegenerative disease therapies.

Authors:  Meng Xu; Tao Feng; Bowen Liu; Fen Qiu; Youhua Xu; Yonghua Zhao; Ying Zheng
Journal:  Theranostics       Date:  2021-08-18       Impact factor: 11.556

Review 9.  The roles of microglia and astrocytes in phagocytosis and myelination: Insights from the cuprizone model of multiple sclerosis.

Authors:  Monokesh K Sen; David A Mahns; Jens R Coorssen; Peter J Shortland
Journal:  Glia       Date:  2022-02-02       Impact factor: 8.073

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.